Effectiveness of Ledipasvir/Sofosbuvir with/without Ribavarin in Liver Transplant Recipients with Hepatitis C

Background and Aims: Recurrent infection of hepatitis C virus (HCV) in liver transplant (LT) recipients is universal and associated with significant morbidity and mortality. Methods: We retrospectively evaluated the safety and efficacy of ledipasvir/sofosbuvir with and without ribavirin in LT recipi...

Descripción completa

Detalles Bibliográficos
Autores principales: Saab, Sammy, Rheem, Justin, Jimenez, Melissa A., Fong, Tiffany M., Mai, Michelle H., Kachadoorian, Caterina A., Esmailzadeh, Negin L., Bau, Sherona N., Kang, Susan, Ramirez, Samantha D., Grotts, Jonathan, Choi, Gina, Durazo, Francisco A., El-Kabany, Mohammed M., Han, Steven-Huy B., Busuttil, Ronald W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: XIA & HE Publishing Inc. 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5472930/
https://www.ncbi.nlm.nih.gov/pubmed/28660147
http://dx.doi.org/10.14218/JCTH.2016.00070

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5472930/
https://www.ncbi.nlm.nih.gov/pubmed/28660147
http://dx.doi.org/10.14218/JCTH.2016.00070

Ejemplares similares